Written by Klarity Editorial Team
Published: May 20, 2026

Last updated: May 20, 2026
Yes — a telehealth provider can evaluate your symptoms, diagnose bacterial vaginosis (BV), and send a prescription for metronidazole or clindamycin to your pharmacy, all without an in-person exam. The entire process typically takes under an hour. Klarity connects you with 2,000+ licensed providers across the US who handle BV evaluations online, seven days a week.
Check if you may qualify for online BV treatment through Klarity →
Bacterial vaginosis is the most common vaginal infection in women of reproductive age, affecting roughly 29% of women between the ages of 14 and 49 in the United States, according to the CDC STI Treatment Guidelines. It occurs when the normal vaginal microbiome — dominated by protective Lactobacillus species — gets disrupted and anaerobic bacteria such as Gardnerella vaginalis, Prevotella species, and Mobiluncus species overgrow.
BV is not a sexually transmitted infection, but sexual activity can alter the vaginal pH and microbiome balance. Douching, antibiotic use, hormonal changes, and a new sexual partner are all recognized risk factors.
Up to 50–75% of people with BV have no symptoms at all, which is one reason it often goes undiagnosed and undertreated.
Clinicians use the Amsel criteria — a four-point framework — to diagnose BV. Three of the four criteria must be present for a confirmed diagnosis.
| Criterion | What it means |
|---|---|
| 1. Homogeneous discharge | Thin, white or gray discharge that coats vaginal walls uniformly |
| 2. Vaginal pH > 4.5 | Elevated pH (normal is 3.8–4.5); measurable with pH strips at home |
| 3. Positive whiff test | Fishy amine odor released when a KOH solution is added to discharge |
| 4. Clue cells on microscopy | Vaginal epithelial cells coated in bacteria visible on wet-mount slide (>20% of cells) |
In a telehealth setting, a provider evaluates your symptom history and often uses your description of discharge color, texture, and odor to apply the Amsel criteria clinically. For recurrent BV or uncertain presentations, some providers may recommend an at-home vaginal swab kit before prescribing.
Yes — telehealth BV treatment is clinically appropriate for most uncomplicated cases. BV does not require a pelvic exam to diagnose when symptom presentation is clear, and metronidazole and clindamycin are non-controlled medications, so there are no federal prescribing restrictions for telehealth (unlike stimulants or certain pain medications).
Telehealth BV visits work well when:
A telehealth provider will likely recommend an in-person visit if you have pelvic pain, fever, unusual bleeding, or symptoms that may indicate pelvic inflammatory disease (PID) — these require hands-on evaluation.
The CDC recommends several antibiotic options for BV. All are available by prescription and can be sent to your preferred pharmacy after a telehealth visit.
| Medication | Form | Regimen | Notes |
|---|---|---|---|
| Metronidazole 500 mg | Oral tablet | Twice daily for 7 days | CDC first-line; avoid alcohol during treatment |
| Metronidazole gel 0.75% | Intravaginal gel | Once daily for 5 days | CDC first-line; lower systemic absorption than oral |
| Clindamycin cream 2% | Intravaginal cream | Once at bedtime for 7 days | CDC first-line; oil-based — can weaken latex condoms |
| Clindamycin 300 mg | Oral tablet | Twice daily for 7 days | Alternative if gel/cream not preferred |
| Tinidazole 2 g | Oral tablet | Once daily for 2 days | Alternative; shorter course than metronidazole oral |
| Secnidazole 2 g | Oral granules | Single dose | FDA-approved 2017; single-dose convenience |
Your telehealth provider selects the regimen based on your allergy history, prior treatment response, and whether you prefer oral or topical treatment. Oral metronidazole 500 mg twice daily for 7 days remains the most prescribed first-line option due to its low cost and strong clinical track record.
See if you may qualify for a same-day BV evaluation through Klarity →
| Care Setting | Visit Cost (without insurance) | Wait Time | Prescription? |
|---|---|---|---|
| Telehealth (e.g., Klarity) | $65–$125 | Under 1 hour | Yes, sent to pharmacy |
| Urgent care clinic | $150–$280 | 1–3 hours | Yes |
| OB-GYN office visit | $200–$400+ | Days to weeks | Yes |
| CVS MinuteClinic | $100–$185 | Same day, variable | Yes |
Telehealth consistently offers the lowest out-of-pocket cost for uncomplicated BV when appointment speed and convenience are factored in.
Many insurance plans may cover telehealth visits for BV treatment, though coverage varies significantly by plan, state, and carrier. Since the COVID-19 pandemic, most major insurers — including Aetna, Cigna, United Healthcare, and Blue Cross Blue Shield plans — expanded telehealth coverage, and many states now have telehealth parity laws requiring insurers to reimburse virtual visits at the same rate as in-person ones.
The prescription cost (metronidazole, clindamycin) is typically covered under standard pharmacy benefits when a prescription is written by a licensed provider, though your specific copay or deductible will apply.
Insurance disclaimer: Coverage for telehealth BV visits varies by individual plan. Klarity recommends verifying your benefits with your insurer before booking. Use the phrase “telehealth evaluation for vaginal infection” when asking your insurer about coverage. Out-of-pocket cost is always available if your plan does not cover telehealth.
Verify whether your plan may cover a Klarity telehealth visit →
BV has a high recurrence rate even after successful treatment. Research published in Sexually Transmitted Diseases (Muzny et al., 2020) documents recurrence rates of 50–80% within 12 months of initial treatment. This is not treatment failure — it reflects the complex, polymicrobial nature of BV and how easily the vaginal microbiome can be disrupted again.
Factors that increase recurrence risk:
For recurrent BV (three or more episodes per year), the CDC recognizes extended suppressive therapy: metronidazole gel 0.75% twice weekly for 4–6 months after an initial 10-day induction course. A telehealth provider can manage recurrent BV and discuss suppressive regimens during an online consultation.
Several home remedies circulate widely for BV — here is a brief evidence review.
Boric acid vaginal suppositories: The most evidence-backed over-the-counter option. A 600 mg intravaginal suppository daily for 14 days shows clinical benefit, particularly for recurrent BV. Boric acid is toxic if swallowed — it is strictly for vaginal use only and should not be used during pregnancy.
Probiotics (oral or vaginal): Lactobacillus-containing probiotic strains (particularly L. rhamnosus and L. reuteri) show modest evidence for reducing BV recurrence when used alongside antibiotic treatment. Evidence for probiotics as standalone treatment remains limited.
Apple cider vinegar, hydrogen peroxide douches, yogurt: No reliable clinical evidence supports these as BV treatments. Hydrogen peroxide douching in particular can disrupt the vaginal microbiome further.
Home remedies do not replace antibiotic treatment for active BV. Use them as adjunctive support, not as a primary intervention.
Telehealth BV treatment is appropriate for most uncomplicated cases. Go to an urgent care or emergency room instead if you have:
Yes. Metronidazole is a non-controlled antibiotic, so telehealth providers can prescribe it without restrictions under the Ryan Haight Act. After a brief symptom evaluation, a licensed provider can send a metronidazole prescription to your pharmacy the same day.
Most people notice symptom improvement within 2–3 days of starting metronidazole or clindamycin. The fishy odor typically resolves first. Complete the full course even after symptoms improve to reduce recurrence risk.
BV sometimes resolves spontaneously, particularly in women with mild or no symptoms. However, untreated BV in symptomatic individuals can increase susceptibility to STIs and is associated with adverse outcomes in pregnancy. Treatment is recommended whenever symptoms are present.
BV is not classified as an STI, but sexual activity — including sex between female partners — can transfer BV-associated bacteria. Male sexual partners do not require treatment. If you have a female partner, they may benefit from evaluation if they develop symptoms.
Recurrent BV (three or more episodes per year) often benefits from extended suppressive antibiotic therapy (metronidazole gel twice weekly for up to 6 months) and adjunctive boric acid suppositories. A telehealth provider can review your recurrence history and recommend a personalized maintenance plan during an online visit.
Telehealth evaluation for BV during pregnancy is available on some platforms, but most guidelines recommend in-person evaluation and testing for pregnant patients given the risk of preterm birth associated with untreated BV. Consult your OB-GYN or midwife if you suspect BV during pregnancy.
Find the right provider for your needs — select your state to find expert care near you.